AptarGroup, a global leader in drug and consumer product dosing, dispensing and protection technologies, has acquired Sommaplast, a Brazil-based specialist in oral dosing pharma packaging solutions. Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups.

Aptar already has manufacturing facilities in Cajamar, Jundiaí, Maringá and Camaçari, Brazil, and this transaction expands its presence in Latin America and brings together shared manufacturing strengths.

“Aptar has manufactured in Brazil for 25 years and this acquisition is expected to further reinforce our footprint in the region. It also helps position us to capitalize on Brazil’s fast-growing oral dosing, over-the-counter and nutraceutical markets. This growth is driven by an expanding population, rising middle class and aging demographic,” explained Gael Touya, President, Aptar Pharma.

Founded more than 20 years ago, Sommaplast operates from a facility in São Paulo and employs over 400 people. The company is well known for its deep customer relationships and extensive know-how in dosing solutions.

Aptar plans to further extend Sommaplast’s offerings in the oral dosing pharma markets through its strong commercial capabilities and expanded product offering. 

 “Together, our operational synergies and precision injection molding expertise will greatly benefit customers. We intend to maintain the DNA of Sommaplast’s family-owned company, while leveraging our global network of solutions, services and product experts,” Touya added.

Headquartered in Crystal Lake, Illinois, Aptar serves a wide range of end markets, including pharmaceutical, beauty, food, beverage, personal care and home care, and employs more than 13,000 people across 20 countries.